Physician profile
Gary Black
NPI 1700149648
$3,778.48
in general payments reported to CMS, 2019-2025
22 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,566 · 2020: $102 · 2021: $81.72 · 2022: $528 · 2023: $741 · 2024: $366 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,501.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,856.94 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $299.76 | 2019-2024 | Senza |
| Lundbeck LLC | $200.05 | 2023-2025 | Vyepti |
| Saluda Medical Americas, INC. | $194.48 | 2025 | Evoke |
| Si-Bone, INC. | $161.02 | 2019 | |
| Collegium Pharmaceutical, INC. | $160.66 | 2020-2025 | Belbuca, Xtampza |
| Grt US Holding, INC. | $160.18 | 2022 | |
| Spr Therapeutics, INC | $100.77 | 2022-2023 | Sprint Pns System |
| Abbvie INC. | $86.80 | 2023 | Ubrelvy, Vraylar, Botox |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.79 | 2019-2024 | Relistor |
| Biodelivery Sciences International, INC. | $81.09 | 2019-2021 | |
| Nalu Medical, INC. | $80.93 | 2023-2024 | Nalu Neurostimulation System |
| Pacira Therapeutics, INC. | $55.72 | 2019-2021 | |
| Amgen INC. | $42.88 | 2019-2022 | |
| Avanos Medical | $42.77 | 2024 | Coolief* Cooled Radiofrequency |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $34.42 | 2025 | Eterna |
| Vertex Pharmaceuticals Incorporated | $33.32 | 2025 | |
| Medtronic USA, INC. | $29.76 | 2019 | |
| Medtronic, INC. | $24.17 | 2023 | Intellis Adaptivestim |
| Lilly USA, LLC | $20.29 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.19 | 2024 | Horizant |
| Scilex Pharmaceuticals INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.